Longitudinal validation of the Maudsley 3-item visual analogue scale (M3VAS): a new, brief, patient-reported outcome measure of depression
Open Access
- 22 December 2025
- journal article
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (1) , e23
Abstract
Background: The Maudsley 3-item visual analogue scale (M3VAS) was developed as a novel and intuitive patient-reported measure for depression, focusing on core symptoms and suicidality. Aims: To evaluate the longitudinal validity of M3VAS for capturing symptom change over time. Method: Both M3VAS and the Patient Health Questionnaire (PHQ-9, as reference standard) were administered in an observational study (RHAPSODY, no. NCT04939818) at weeks 0, 2 and 4 to both depressed patients ( n = 50) and matched controls ( n = 24). We serially tested factor structure, internal consistency and convergence (correlation) over time, assessing responsiveness by both correlation of change in score and effect of time across scales (analysis of variance and effect size). Results: M3VAS exhibited strong factor loadings and high item interrelatedness (Cronbach’s alpha 0.78–0.83) at all time points. Total scores correlated strongly with PHQ-9 at each time point ( r > 0.8, P < 0.001). Correlation of score change over the study period ( r = 0.65, P < 0.001) also confirmed responsiveness. In the depressed group, an effect of time on score was seen for both M3VAS ( F = 4.942, P = 0.010) and PHQ-9 ( F = 12.505, P < 0.001), with standard response mean (Cohen’s d ) of 0.58 and 0.74, respectively. No effect of time was seen in the control group. Conclusions: Following previous cross-sectional validation against the Quick Inventory of Depressive Symptomatology–Self-report, this present study demonstrated appropriate longitudinal measurement properties for M3VAS as a measure of depression, including responsiveness. Evaluating the ability of M3VAS to discern responses with a variety of treatments is a key future goal.Keywords
This publication has 46 references indexed in Scilit:
- Associations of somatic depressive symptoms with body mass index, systemic inflammation, and insulin resistance in primary care patients with depressionJournal of Behavioral Medicine, 2022
- A Single-Item Visual Analogue Scale (VAS) Measure for Assessing Depression Among College StudentsCommunity Mental Health Journal, 2019
- COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome MeasuresQuality of Life Research, 2017
- Sensitivity to Change of Patient‐Preference Measures for Pain in Patients With Knee Osteoarthritis: Data From Two TrialsArthritis Care & Research, 2016
- Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain Criteria (RDoC)Journal of Affective Disorders, 2014
- The natural course and outcome of major depressive disorder in primary care: the PREDICT-NL studySocial Psychiatry and Psychiatric Epidemiology, 2010
- Factor Structure and Predictive Validity of Somatic and Nonsomatic Symptoms From the Patient Health Questionnaire-9: A Longitudinal Study After Spinal Cord InjuryArchives of Physical Medicine and Rehabilitation, 2010
- A three-factor model of the MADRS in major depressive disorderDepression and Anxiety, 2005
- Independent Assessment of Manic and Depressive Symptoms by Self-ratingArchives of General Psychiatry, 1991
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951